Financial Reports & Notices

01. Available Documents
01. Available Documents Toggle Icon
Trinity Biotech Financial Results for Quarter 1, 2026
Trinity Biotech Financial Results Q4 & Full Year 2025
Trinity Biotech Financial Results Q3 2025
Trinity Biotech Financial Results Q2 2025
Form 20-F 2024
AGM 2024

2024 AGM Board’s Letter Sent to holders of Ordinary Shares   

*ADS holders should contact their brokers if they have any questions about voting their ADSs

 

2024 AGM Notice Sent to holders of Ordinary Shares   

*ADS holders should contact their brokers if they have any questions about voting their ADSs

2023 AGM Notice Sent to holders of Ordinary Shares*

*ADS holders should contact their brokers if they have any questions about voting their ADSs

2023 AGM Notice Sent to holders of Ordinary Shares Document

2023 AGM Board's Letter Sent to holders of Ordinary Shares**

**ADS holders should contact their brokers if they have any questions about voting their ADSs

2023 AGM Board’s Letter Sent to holders of Ordinary Shares Document

Trinity Biotech Annual Report 2022
Form 20-F 2022
Trinity Biotech Constitution 2022 - Marked to Highlight Proposed Changes
2022 AGM Notice Sent to holders of Ordinary Shares*

*ADS holders should contact their brokers if they have any questions about voting their ADSs

2022 AGM Notice Sent to holders of Ordinary Shares Document

2022 AGM Board's Letter Sent to holders of Ordinary Shares**

**ADS holders should contact their brokers if they have any questions about voting their ADSs

2022 AGM Board’s Letter Sent to holders of Ordinary Shares Document

Trinity Biotech Annual Report 2021
Form 20-F 2021